Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000642028 | SCV000763681 | likely benign | Tuberous sclerosis 1 | 2024-11-20 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002257897 | SCV002531485 | uncertain significance | Hereditary cancer-predisposing syndrome | 2022-01-03 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV002257897 | SCV002677360 | likely benign | Hereditary cancer-predisposing syndrome | 2020-07-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV004692008 | SCV005190547 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
All of Us Research Program, |
RCV004802325 | SCV005426983 | likely benign | Tuberous sclerosis syndrome | 2024-04-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV004692008 | SCV005437559 | uncertain significance | not provided | 2024-06-10 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown. |